Giving adolescents same-day access to long-acting reversible contraceptives (LARC) in a Medicaid setting may save insurers money, according to results of a new economic evaluation.
Giving adolescents same-day access to long-acting reversible contraceptives (LARC) in a Medicaid setting may save insurers money, according to results of a new economic evaluation. The authors of the report on the research, which appears in JAMA Network Open, said the model of care should be explored in other settings as a way to increase access to contraception and lower rates of unintended pregnancy.
The analysis was based on development of a decision model from the perspective of Medicaid in Indiana. The authors made some simple assumptions about a hypothetical base case: a 16-year-old patient who presented for care and wanted LARC. They said that the assumptions generally would bias against same-day LARC because they ignore some of the costs of unintended pregnancy.
Although insurers typically do not require two visits for insertion of LARC, in many clinics that is the process, according to the authors, because of barriers within clinical and billing systems and the cost of stocking LARC. To test the one-visit model, they used data from previous studies to work through all the scenarios that could result if an adolescent wanted same-day LARC. For each step, the cost to the payer was calculated-including expenses such as for the device itself, delivery of a baby, and cost of an annual visit.
Same-day LARC placement was associated with lower overall costs ($2016 per patient over 1 year) compared with placement at a subsequent visit ($4133 per patient over 1 year). Compared with the return-visit strategy, same-day LARC was associated with an unintended pregnancy rate of 14% versus 48% and an abortion rate of 4% versus 14%.
Describing the results, the authors said that this was “the first cost-minimization analysis done from the outpatient perspective. The cost savings calculated here provide a benchmark for policy makers to consider potential policy changes and investments in incentives to promote and provide same-day LARC.” Noting that Medicaid insures an at-risk, low-income population and covers almost half the births in the United States, the researchers recommended that the agency foster same-day access to contraception through four strategies:
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More